darunavir has been researched along with Cardiovascular Stroke in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 4 (100.00) | 2.80 |
Authors | Studies |
---|---|
Mejias, A; Peeples, ME; Ramilo, O; Teng, MN | 1 |
Boccara, F; Costagliola, D; Cotte, L; de Castro, N; Duval, X; Duvivier, C; Grabar, S; Katlama, C; Lang, S; Mary-Krause, M; Partisani, M; Potard, V; Raffi, F; Ronot-Bregigeon, S; Simon, A; Tattevin, P; Weiss, L; Zucman, D | 1 |
Siedner, MJ; Triant, VA | 1 |
Chan, WW; Li, M; Zucker, SD | 1 |
4 other study(ies) available for darunavir and Cardiovascular Stroke
Article | Year |
---|---|
Live Attenuated Vaccine With a Stabilized Mutation and Gene Deletion for Prevention of Respiratory Syncytial Virus Disease in Young Children.
Topics: Atazanavir Sulfate; Case-Control Studies; Child; Child, Preschool; Darunavir; Gene Deletion; HIV; HIV Infections; Humans; Myocardial Infarction; Respiratory Syncytial Virus Infections; Respiratory Syncytial Viruses | 2020 |
Is the Risk of Myocardial Infarction in People With Human Immunodeficiency Virus (HIV) Associated With Atazanavir or Darunavir? A Nested Case-Control Study Within the French Hospital Database on HIV.
Topics: Adult; Atazanavir Sulfate; Case-Control Studies; Cohort Studies; Darunavir; Databases, Factual; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Myocardial Infarction; Risk Factors; Treatment Outcome | 2020 |
Darunavir and Cardiovascular Risk: Evaluating the Data to Inform Clinical Care.
Topics: Atazanavir Sulfate; Cardiovascular Diseases; Case-Control Studies; Darunavir; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Myocardial Infarction; Risk Factors | 2020 |
Association Between Atazanavir-Induced Hyperbilirubinemia and Cardiovascular Disease in Patients Infected with HIV.
Topics: Atazanavir Sulfate; Bilirubin; Cardiovascular Diseases; Darunavir; Female; HIV Infections; HIV Protease Inhibitors; Humans; Hyperbilirubinemia; Ischemic Stroke; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Time Factors | 2020 |